The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Valorum will advance the commercialization and distribution of Armlupeg in the United States
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
Growing patent filings and tier-2 innovators reflect expanding national research base
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Subscribe To Our Newsletter & Stay Updated
